Examining dietary supplements containing Euterpe oleracea Mart. (açaí) for potential botanical-drug interactions involving CYP3A4 inhibition

• Главные авторы: Kabre L. Heck (Автор), Lauren M. Fogel (Автор), Destini Thornton (Автор), Madeline L. Kunze (Автор), Meredith Almy (Автор), Angela I. Calderón (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2024-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Botanical dietary supplements (BDS) are consumed more by cancer patients than otherwise healthier patients to alleviate side effects of chemotherapy drugs or increase quality of life. The enzyme responsible for the metabolism of most anticancer drugs is CYP3A4, an enzyme predominantly lo...